Kenvue Inc. (KVUE)
Data as of , from SEC Form 4 filings.
See up to 3 months of KVUE. The 7-day demo opens the 1M and 3M ranges and puts KVUE on your watchlist.
Start 7-day demoLatest KVUE insider trades
About Kenvue Inc. (KVUE)
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
- SUMMIT, NJ
- 22,000
- 2023
- XNYS
KVUE Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 7 | 146,318 | |
| Option exercise | 8 | 167,818 | |
| Tax withholding / forfeiture | 7 | 66,470 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
KVUE insider transactions (Form 4)
5493 Form 4 filings on record, the earliest from Dec 3, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Carlton Lawson - Officer | Grant or award | Common Stock | 36,597 footnote F1 | $17.20 | $629K | |
| ||||||
| Matthew Orlando - Officer | Grant or award | Common Stock | 35,754 footnote F1 | $17.20 | $615K | |
| Matthew Orlando - Officer | Tax withholding / forfeiture | Common Stock | 14,749 footnote F2 | $17.20 | $254K | |
| ||||||
| Meredith Stevens - Officer | Grant or award | Common Stock | 35,754 footnote F1 | $17.20 | $615K | |
| Meredith Stevens - Officer | Tax withholding / forfeiture | Common Stock | 15,192 footnote F2 | $17.20 | $261K | |
| ||||||
| Caroline Tillett - Officer | Grant or award | Common Stock | 24,732 footnote F1 | $17.20 | $425K | |
| Caroline Tillett - Officer | Tax withholding / forfeiture | Common Stock | 8,471 footnote F2 | $17.20 | $146K | |
| ||||||
| Heather Howlett - Officer | Grant or award | Common Stock | 10,881 footnote F1 | $17.20 | $187K | |
| Heather Howlett - Officer | Tax withholding / forfeiture | Common Stock | 5,566 footnote F2 | $17.20 | $96K | |
| ||||||
| Michael Wondrasch - Officer | Option exercise | Common Stock | 66,029 | - footnote F1 | - | |
| Michael Wondrasch - Officer | Tax withholding / forfeiture | Common Stock | 21,031 footnote F2 | $17.22 | $362K | |
| Michael Wondrasch - Officer | Option exercise | Restricted Stock Units | 66,029 | $0.00 | - | |
| ||||||
| Jeffrey C. Smith - Director | Grant or award | Deferred Share Units | 1,300 | - footnote F2 | - | |
| ||||||
| Meredith Stevens - Officer | Option exercise | Common Stock | 429 | - footnote F1 | - | |
| Meredith Stevens - Officer | Tax withholding / forfeiture | Common Stock | 429 footnote F2 | $17.81 | $8K | |
| Meredith Stevens - Officer | Option exercise | Common Stock | 1,032 | - footnote F1 | - | |
| Meredith Stevens - Officer | Tax withholding / forfeiture | Common Stock | 1,032 footnote F2 | $17.81 | $18K | |
| Meredith Stevens - Officer | Option exercise | Restricted Stock Units | 429 | - footnote F1 | - | |
| Meredith Stevens - Officer | Option exercise | Restricted Stock Units | 1,032 | - footnote F1 | - | |
| ||||||
| Richard E. Allison Jr. - Director | Grant or award | Deferred Share Units | 1,300 | - footnote F1 | - | |
| ||||||
| Anindya Dasgupta - Officer | Option exercise | Common Stock | 16,419 footnote F1 | $0.00 | - | |
| Anindya Dasgupta - Officer | Option exercise | Restricted Stock Units | 16,419 | $0.00 | - | |
| ||||||
| Jeffrey C. Smith - Director | Grant or award | Deferred Share Units | 1,413 | - footnote F2 | - | |
| ||||||
| Richard E. Allison Jr. - Director | Grant or award | Deferred Share Units | 1,413 | - footnote F1 | - | |
| ||||||
| Heather Howlett - Officer | Open-market sale | Common Stock | 3,700 | $18.11 | $67K | |
| Jeffrey C. Smith - Director | Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | |
| Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | ||
| Betsy D. Holden - Director | Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | |
| Larry J. Merlo - Director | Grant or award | Deferred Share Units | 16,036 | $17.46 | $280K | |
| Vasant M. Prabhu - Director | Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | |
| Michael E. Sneed - Director | Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | |
| Gomes de Lemos Leonardo Curado - Officer | Option exercise | Common Stock | 24,248 | $0.00 | - | |
| Gomes de Lemos Leonardo Curado - Officer | Tax withholding / forfeiture | Common Stock | 7,141 footnote F1 | $17.43 | $124K | |
| Gomes de Lemos Leonardo Curado - Officer | Option exercise | Restricted Stock Units | 24,248 | $0.00 | - | |
| ||||||
| Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | ||
| Kathleen M. Pawlus - Director | Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | |
| Richard E. Allison Jr. - Director | Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | |
| Erica L. Mann - Director | Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | |
| Seemantini Godbole - Director | Grant or award | Deferred Share Units | 10,309 | $17.46 | $180K | |
| Matthew Orlando - Officer | Open-market sale | Common Stock | 38,491 | $17.66 footnote F1 | $680K | |
| ||||||
| Jeffrey C. Smith - Director | Grant or award | Deferred Share Units | 1,331 | - footnote F2 | - | |
| ||||||
| Richard E. Allison Jr. - Director | Grant or award | Deferred Share Units | 1,331 | - footnote F1 | - | |
| ||||||
| Meredith Stevens - Officer | Tax withholding / forfeiture | Common Stock | 358 footnote F2 | $18.16 | $7K | |
| Meredith Stevens - Officer | Option exercise | Restricted Stock Units | 4,329 | $0.00 | - | |
| Meredith Stevens - Officer | Option exercise | Restricted Stock Units | 840.35 | $0.00 | - | |
| Meredith Stevens - Officer | Option exercise | Common Stock | 4,329 | $0.00 | - | |
| Meredith Stevens - Officer | Option exercise | Common Stock | 840.35 | $0.00 | - | |
| Meredith Stevens - Officer | Tax withholding / forfeiture | Common Stock | 1,738 footnote F1 | $17.96 | $31K | |
| ||||||
| Luani Alvarado - Officer | Option exercise | Restricted Stock Units | 696.93 | $0.00 | - | |
| Luani Alvarado - Officer | Option exercise | Common Stock | 3,525 | $0.00 | - | |
| Luani Alvarado - Officer | Option exercise | Common Stock | 696.93 | $0.00 | - | |
| Luani Alvarado - Officer | Tax withholding / forfeiture | Common Stock | 1,721 footnote F1 | $17.96 | $31K | |
| Luani Alvarado - Officer | Tax withholding / forfeiture | Common Stock | 357 footnote F2 | $18.16 | $6K | |
| Luani Alvarado - Officer | Option exercise | Restricted Stock Units | 3,525 | $0.00 | - | |
| ||||||
Recent KVUE Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
Stock trades in KVUE disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
| Sale (partial) |
KVUE insider trading FAQ
What is the latest insider trade for KVUE?
Kenvue Inc. (KVUE) had 10 insider filings in the last 90 days, with the most recent on 2026-10-07. The full record for KVUE runs to 93 Form 4 filings, the earliest from 2024-12-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying KVUE stock?
No insider purchases of KVUE were filed in the last 90 days.
How many insiders are selling KVUE stock?
No insider sales of KVUE were filed in the last 90 days. 2 sales are on record for this company.
Where can I see KVUE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects KVUE Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Consumer Staples companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Carlton Lawson view on EDGAR
- - Matthew Orlando view on EDGAR
- - Meredith Stevens view on EDGAR
- - Caroline Tillett view on EDGAR
- - Heather Howlett view on EDGAR
- - Michael Wondrasch view on EDGAR
- - Jeffrey C. Smith view on EDGAR
- - Meredith Stevens view on EDGAR
- - Richard E. Allison Jr. view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Consumer Staples
- Where KVUE's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow KVUE with a 7-day demo
- KVUE on your watchlist
- Every KVUE Form 4 filing on record
- Up to 3 months of KVUE price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive